Advertisement

Index by author

November 01, 2000; Volume 295,Issue 2

  1. Feelisch, Martin

    1. Inhibition of Endothelial Cell Activation by Nitric Oxide Donors
      Antonella Zampolli, Giuseppina Basta, Guido Lazzerini, Martin Feelisch and Raffaele De Caterina
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 818-823;

  2. Fernandez, Argentina

    1. Rationale for the Combination of PGE1 andS-Nitroso-glutathione to Induce Relaxation of Human Penile Smooth Muscle
      Javier Angulo, Pedro Cuevas, Ignacio Moncada, Antonio Martín-Morales, Antonio Allona, Argentina Fernández, Sonia Gabancho, Peter Ney and Iñigo Sáenz de Tejada
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 586-593;

  3. Ferrans, Victor J.

    1. The Catalytic DNA Topoisomerase II Inhibitor Dexrazoxane (ICRF-187) Induces Endopolyploidy in Chinese Hamster Ovary Cells
      Brian B. Hasinoff, Michael E. Abram, Gaik-Lean Chee, Erwin Huebner, Edward H. Byard, Norman Barnabé, Victor J. Ferrans, Zu-Xi Yu and Jack C. Yalowich
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 474-483;

  4. Ferrier, Gregory R.

    1. Losartan Improves Recovery of Contraction and Inhibits Transient Inward Current in a Cellular Model of Cardiac Ischemia and Reperfusion
      William E. Louch, Gregory R. Ferrier and Susan E. Howlett
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 697-704;

  5. Figtree, Gemma A.

    1. Tamoxifen Acutely Relaxes Coronary Arteries by an Endothelium-, Nitric Oxide-, and Estrogen Receptor-Dependent Mechanism
      Gemma A. Figtree, Carolyn M. Webb and Peter Collins
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 519-523;

  6. Fitzgerald, Desmond J.

    1. Glycoprotein IIb/IIIa Receptor Number and Occupancy during Chronic Administration of an Oral Antagonist
      Martin J. Quinn, Dermot Cox, J. Brendan Foley and Desmond J. Fitzgerald
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 670-676;

  7. Foley, J. Brendan

    1. Glycoprotein IIb/IIIa Receptor Number and Occupancy during Chronic Administration of an Oral Antagonist
      Martin J. Quinn, Dermot Cox, J. Brendan Foley and Desmond J. Fitzgerald
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 670-676;

  8. Fortin, David

    1. Protective Effect of Omapatrilat, a Vasopeptidase Inhibitor, on the Metabolism of Bradykinin in Normal and Failing Human Hearts
      Charles Blais, David Fortin, Jean-Lucien Rouleau, Giuseppe Molinaro and Albert Adam
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 621-626;

  9. Fraser, Amy B.

    1. Endothelin Receptor Antagonism Does Not Prevent the Development of In Vivo Glyceryl Trinitrate Tolerance in the Rat
      Jodan D. Ratz, Amy B. Fraser, Karen J. Rees-Milton, Michael A. Adams and Brian M. Bennett
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 578-585;

  10. Freijs, Agneta

    1. Semiphysiological Model for the Time Course of Leukocytes after Varying Schedules of 5-Fluorouracil in Rats
      Lena E. Friberg, Agneta Freijs, Marie Sandström and Mats O. Karlsson
      Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 734-740;
« Previous (Pages : 3 4 5 6 7 8 9 10 11 12 ... 26) Next »
Back to top

In this issue

Advertisement